We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
+3.49%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
–
AUM
$113M
AUM Growth
+$1.69M
(+1.5%)
Cap. Flow
-$86.1K
Cap. Flow
% of AUM
-0.08%
Top 10 Holdings %
Top 10 Hldgs %
24.81%
Holding
128
New
10
Increased
15
Reduced
46
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CALL
magicJack VocalTec Ltd
CALL
|
+$1.04M |
| 2 |
MEMP
Memorial Production Partners LP Common Units
MEMP
|
+$987K |
| 3 |
Navigator Holdings
NVGS
|
+$984K |
| 4 |
VIVO
Meridian Bioscience Inc
VIVO
|
+$920K |
| 5 |
Itron
ITRI
|
+$903K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.85M |
| 2 |
AFOP
Alliance Fiber Optic Prod Inc
AFOP
|
+$1.59M |
| 3 |
Encore Capital Group
ECPG
|
+$1.58M |
| 4 |
AFFX
Affymetrix Inc
AFFX
|
+$1.29M |
| 5 |
EPIQ
EPIQ SYSTEMS INC
EPIQ
|
+$909K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.12% |
| 2 | Healthcare | 16.33% |
| 3 | Energy | 11.29% |
| 4 | Financials | 10.56% |
| 5 | Industrials | 7.12% |
Similar funds
IWM
EP
AC
SF
LAM
HAM
HEM
CF
Penbrook Management's Q1 2015 Portfolio in Review
As of Q1 2015, Penbrook Management held 128 positions worth $113M, up 1.5% from $111M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Penbrook Management's Q1 2015 filing shows 10 new, 15 increased, 46 reduced and 12 closed positions. Its largest new stake was magicJack VocalTec Ltd: 137,200 shares worth $938K. The largest sale was Allergan Inc, an estimated $1.85M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Energy.
- Penbrook Management's largest Q1 2015 buy was magicJack VocalTec Ltd: 137,200 shares worth $938K.
- Penbrook Management added most to Zix Corporation in Q1 2015, an estimated $892K increase.
- Penbrook Management's biggest Q1 2015 reduction was Affymetrix Inc, cutting an estimated $1.29M.
- Penbrook Management fully exited Allergan Inc in Q1 2015, selling an estimated $1.85M.
- Penbrook Management's ten largest holdings make up 25% of its $113M portfolio in Q1 2015.
- Penbrook Management opened 10 new positions and closed 12 in Q1 2015.
- Penbrook Management's portfolio value rose 1.5% quarter-over-quarter to $113M.
Based on Penbrook Management's 13F filing for Q1 2015, filed 27 Apr 2015.